Trademark 79141143 - Trademark Alertz

Trademark: 79141143

Word

Status

Dead

Status Code

404

Status Date

Friday, August 18, 2023

Serial Number

79141143

Registration Number

4566080

Registration Date

Tuesday, July 15, 2014

Mark Type

Filing Date

Monday, August 19, 2013

Published for Opposition

Tuesday, April 29, 2014

Cancellation Date

Friday, August 18, 2023

Trademark Owner History

ELSEVIER LIMITED -
Elsevier Life Sciences IP LTD -
RELX Intellectual Properties SA - Original Registrant
Reed Elsevier Properties SA - Owner At Publication

Classifications

41 Publishing non-downloadable electronic publications provided on-line, namely, magazines, periodicals, books, manuals, prospectuses, newsletters, pamphlets, newspapers, reviews, articles, catalogs, indexes, advertising and promotional material; electronic desktop publishing for others and publishing of magazines, periodicals, books, manuals, prospectuses, newsletters, pamphlets, newspapers, reviews, articles, catalogs, indexes, and advertising and promotional material connected with presentations and exhibitions, colloquia, conventions, seminars, workshops and events for educational purposes; educational and training services, namely, organizing, running and conducting of exhibitions, conferences, congresses, symposia, seminars, readings, conventions, training workshops and events for educational purposes, all in the fields of drug discovery and development, chemistry, science, medicine, biomedicine, pharmacology, biology and molecular biology; education and training services namely, mentoring in the fields of drug discovery and development, chemistry, science, medicine, biomedicine, pharmacology, biology and molecular biology; education and training services, namely, curriculum development for others; providing educational information in the fields of drug discovery and development, chemistry, science, medicine, biomedicine, pharmacology, biology and molecular biology for participants, visitors and exhibitors at exhibitions, conferences, congresses, symposia, colloquia, seminars, readings, conventions, workshops and events for educational purposes, provided face-to-face and electronically via the Internet

9 Computer programs and software used for searching databases for use in the fields of drug discovery and development, chemistry, science, medicine, biomedicine, pharmacology, biology and molecular biology ; word processing software and word processing computer programs; downloadable electronic publications, namely, magazines, periodicals, books, manuals, prospectuses, newsletters, pamphlets, newspapers, reviews, articles, catalogs, blogs, indexes, advertising and promotional materials, all in the fields of drug discovery and development, chemistry, science, medicine, biomedicine, pharmacology, biology and molecular biology; downloadable computer search engine software; pre-recorded compact disks, DVDs and CD-ROMs featuring information in the fields of drug discovery and development, chemistry, science, medicine, biomedicine, pharmacology, biology and molecular biology

42 Scientific research; industrial research in the fields of drug discovery and development, chemistry, science, medicine, biomedicine, pharmacology, biology and molecular biology; computer services, namely providing scientific information in the field of medical, biomedical, pharmaceutical, biological and molecular biology research provided from a computer database via a global computer network; consultancy and providing scientific information in the field of medical, biomedical, pharmaceutical, biological and molecular biology research; scientific research, computer-assisted; conversion of data or documents in physical form to electronic data or documents; data conversion of computer data; providing temporary use of on-line non-downloadable software for searching databases for use in the fields of drug discovery and development, chemistry, science, medicine, biomedicine, pharmacology, biology and molecular biology; provision of scientific information in the field of medical, biomedical, pharmaceutical, biological and molecular biology research

The mark consists of a triangle with one curved side, with five lines crossing the triangle vertically, horizontally and diagonally, with small circles marking the points where the lines intersect.
Color is not claimed as a feature of the mark.

Trademark Events

Jan 8, 2014

Assigned To Examiner

Jan 3, 2014

Sn Assigned For Sect 66a Appl From Ib

Jan 8, 2014

New Application Office Supplied Data Entered

Mar 9, 2014

Approved For Pub - Principal Register

Jan 14, 2014

Application Filing Receipt Mailed

Jan 15, 2014

Non-Final Action Written

Jan 16, 2014

Non-Final Action (Ib Refusal) Prepared For Review

Jan 16, 2014

Refusal Processed By Mpu

Jan 16, 2014

Non-Final Action Mailed - Refusal Sent To Ib

Feb 2, 2014

Refusal Processed By Ib

Feb 4, 2014

Teas Response To Office Action Received

Feb 4, 2014

Correspondence Received In Law Office

Feb 4, 2014

Teas/Email Correspondence Entered

Oct 15, 2014

Final Disposition Notice Created, To Be Sent To Ib

Mar 24, 2014

Assigned To Lie

Mar 25, 2014

Law Office Publication Review Completed

Apr 9, 2014

Notification Of Notice Of Publication E-Mailed

Apr 9, 2014

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Apr 9, 2014

Notification Of Possible Opposition Sent To Ib

Apr 25, 2014

Notification Processed By Ib

Apr 29, 2014

Published For Opposition

Apr 29, 2014

Official Gazette Publication Confirmation E-Mailed

Jul 15, 2014

Registered-Principal Register

Jul 15, 2019

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Jan 13, 2015

Final Disposition Processed

Jan 13, 2015

Final Disposition Notice Sent To Ib

Feb 14, 2015

Final Decision Transaction Processed By Ib

Mar 24, 2016

Change Of Name/Address Rec'd From Ib

May 16, 2019

Change Of Owner Received From Ib

May 23, 2019

Change Of Owner Received From Ib

Feb 26, 2021

Cancelled Section 71

Oct 26, 2021

Total Invalidation Of Reg Ext Protection Created

Mar 8, 2022

Invalidation Processed

Mar 8, 2022

Total Invalidation Of Reg Ext Protection Sent To Ib

Mar 17, 2024